To deliver COVID-19 therapies and vaccines, pharma companies have needed to deploy all necessary means to accelerate the development and release of safe, effective drugs to the world.
We provide leading pharmaceutical and COVID-19 therapy developers with a rapid sterility solution and validation support, allowing organizations to offload their validation testing to Charles River Laboratories and implement Celsis® for rapid sterility in less than six months.
Everywhere you look today, special interest stories and commentary are trying to shape our decisions rather than objective, scientific data. The pharmaceutical industry is no different.
That’s why our Endosafe® products rely on science and research to deliver the most trusted endotoxin testing solutions in the world, ensuring the safety of millions of patients each year.
The COVID-19 pandemic created inspiring partnerships in the pharmaceutical industry, all toward a common goal – to deliver safe and effective COVID-19 therapies and critical pharmaceuticals to the world as quickly and safely as possible.
Timing was everything, which is why our Accugenix® laboratories worked around the clock, in split shifts and throughout shutdowns, to make sure your microbial identification results were there when you needed them.